Researchers analyzed data from patients with severe respiratory diseases in intensive care units. They looked at the relationship between a specific measure called the HbA1c-adjusted stress hyperglycemia ratio (SHR) and the risk of short-term mortality.
The analysis found a significant link between higher SHR levels and an increased risk of death. Specifically, for every 0.1 unit increase in the SHR, the risk of short-term mortality rose by about 5 percent. This suggests a steady increase in risk as the ratio goes up.
It is important to note that this study shows a link, not a direct cause. Some parts of the data were less consistent because of a small number of studies and wide confidence intervals. Because the evidence for complex patterns is not yet clear, these findings are currently used to identify a risk factor rather than to change immediate treatment plans.
Common questions
What is the risk for patients with high stress hyperglycemia?
The study found that a higher stress hyperglycemia ratio (SHR) is associated with an increased risk of short-term mortality in patients with severe respiratory diseases. Specifically, for every 0.1-unit increase in the SHR, there was approximately a 5% increase in the risk of death.
Is this finding certain for all patients?
The evidence shows a link, but it is not a definitive proof of cause. Some data points were less precise due to a limited number of studies and wide confidence intervals. Because of these limitations, the findings are currently considered a link rather than a confirmed clinical rule.
How consistent was the data regarding mortality risk?
The results based on hazard ratios (HR) were more consistent than those based on odds ratios (OR). While the HR-based data showed a clear link between higher SHR and mortality, the OR-based data did not reach statistical significance and showed more variation.
